RNS Number : 3093J

Advanced Medical Solutions Grp PLC

27 June 2017

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Advanced Medical Solutions Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the
notification obligation:

Octopus Investments Nominees Limited

4. Full name of shareholder(s) (if different from 3.):

n/a

5. Date of the transaction and date on
which the threshold is crossed or
reached:

23/06/2017

6. Date on which issuer notified:

26/06/2017

7. Threshold(s) that is/are crossed or
reached:

9%

8. Notified details:n/a

A: Voting rights attached to shares

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0004536594

19,004,675

19,004,675

19,256,735

19,256,735

9.10%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

19,256,735

9.10%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

n/a

Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease to hold:

n/a

12. Date on which proxy holder will cease to hold voting rights:

n/a

13. Additional information:

14. Contact name:

Daryl O'Brien

15. Contact telephone number:

0203 1400 942

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

Peter Orsi

Contact address

(registered office for legal entities)

33 Holborn, London, EC1N 2HT

Phone number & email

020 7710 2877

Other useful information

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

Contact address

Phone number & email

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FCA website.

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAEKXASPXEFF

Advanced Medical Solutions Group plc published this content on 27 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 27 June 2017 13:39:11 UTC.

Original documenthttps://www.admedsol.com/investor-relations/regulatory-news-announcements/3352124-3128/

Public permalinkhttp://www.publicnow.com/view/428E2ABB857986AAD33F85FC9F0DA311A483E132